We are live on ! Find out more
PIC

Portland Investment Counsel Portfolio holdings

AUM $312M
1-Year Est. Return 53.32%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+53.32%
3 Year Est. Return
+103.89%
5 Year Est. Return
+49.43%
10 Year Est. Return
–
AUM
$278M
AUM Growth
+$858K
Cap. Flow
-$25M
Cap. Flow %
-8.97%
Top 10 Hldgs %
78.65%
Holding
59
New
7
Increased
10
Reduced
3
Closed
8

Top Buys

Rank Stock Value
1
OKLO
Oklo
OKLO
+$5.9M
2
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$1.05M
3
CCJ icon
Cameco
CCJ
+$262K
4
ICLR icon
Icon
ICLR
+$252K
5
CVS icon
CVS Health
CVS
+$245K

Top Sells

Rank Stock Value
1
CM icon
Canadian Imperial Bank of Commerce
CM
+$10.5M
2
SBUX icon
Starbucks
SBUX
+$8.69M
3
ADM icon
Archer Daniels Midland
ADM
+$6.47M
4
DHI icon
D.R. Horton
DHI
+$5.04M
5
RY icon
Royal Bank of Canada
RY
+$1.2M

Sector Composition

Rank Sector Weight
1 Financials 49.56%
2 Communication Services 20.17%
3 Healthcare 12.23%
4 Materials 5.33%
5 Consumer Discretionary 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIL icon
26
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$1.05M 0.38%
+11,467
New +$1.05M
CATX icon
27
Perspective Therapeutics
CATX
$372M
$935K 0.34%
70,001
– –
MSFT icon
28
Microsoft
MSFT
$3.66T
$920K 0.33%
2,137
– –
CCJ icon
29
Cameco
CCJ
$43.1B
$860K 0.31%
18,000
+6,000
+50% +$262K
BTE icon
30
Baytex Energy
BTE
$3.05B
$838K 0.3%
280,300
– –
BMO icon
31
Bank of Montreal
BMO
$129B
$722K 0.26%
8,000
– –
LILAK icon
32
Liberty Latin America Class C
LILAK
$1.67B
$683K 0.25%
78,456
– –
ONC
33
BeOne Medicines Ltd
ONC
$40.6B
$674K 0.24%
3,000
+1,000
+50% +$180K
MA icon
34
Mastercard
MA
$490B
$673K 0.24%
1,363
– –
VRN
35
DELISTED
Veren
VRN
$624K 0.22%
101,200
-6,880
-6% -$49.2K
CEG icon
36
Constellation Energy
CEG
$98.7B
$468K 0.17%
1,800
+300
+20% +$59.6K
SMR icon
37
NuScale Power
SMR
$3.94B
$463K 0.17%
40,000
– –
LEU icon
38
Centrus Energy
LEU
$3.69B
$439K 0.16%
8,000
+1,500
+23% +$62.7K
BBIO icon
39
BridgeBio Pharma
BBIO
$16.4B
$382K 0.14%
15,000
– –
IOVA icon
40
Iovance Biotherapeutics
IOVA
$3.05B
$376K 0.13%
40,000
+10,000
+33% +$94.7K
REGN icon
41
Regeneron Pharmaceuticals
REGN
$82.2B
$341K 0.12%
324
– –
BWXT icon
42
BWX Technologies
BWXT
$15.8B
$326K 0.12%
3,000
– –
CRWD icon
43
CrowdStrike
CRWD
$226B
$236K 0.08%
+3,372
New +$239K
ICLR icon
44
Icon
ICLR
$12.9B
$230K 0.08%
+800
New +$252K
HEI icon
45
HEICO Corp
HEI
$52.1B
$211K 0.08%
+808
New +$195K
SU icon
46
Suncor Energy
SU
$74.7B
$207K 0.07%
5,600
– –
NUVL
47
DELISTED
Nuvalent
NUVL
$205K 0.07%
+2,000
New +$166K
OLMA icon
48
Olema Pharmaceuticals
OLMA
$913M
$143K 0.05%
+12,000
New +$153K
PLUG icon
49
Plug Power
PLUG
$3.2B
$113K 0.04%
50,000
– –
RLAY icon
50
Relay Therapeutics
RLAY
$4.4B
$70.8K 0.03%
+10,000
New +$74.7K
1
2
3

Similar funds

CFLC
California First Leasing Corp Newport Beach, California $312M AUM 67.74% 1-Year Est. Return
TL
Tradewinds LLC Raleigh, North Carolina $310M AUM 22.31% 1-Year Est. Return
IPW
IronBridge Private Wealth Austin, Texas $310M AUM 41.13% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
RGC
Redwood Grove Capital Palo Alto, California $310M AUM 35.87% 1-Year Est. Return
IR
IAT Reinsurance New York $310M AUM 13.37% 1-Year Est. Return
MIM
Moseley Investment Management Bradenton, Florida $314M AUM 22.17% 1-Year Est. Return
CCG
Cloverfields Capital Group Minneapolis, Minnesota $309M AUM 20.93% 1-Year Est. Return

Portland Investment Counsel's Q3 2024 Portfolio in Review

As of Q3 2024, Portland Investment Counsel held 59 positions worth $278M, up 0.31% from $278M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Portland Investment Counsel withdrew a net $25M in Q3 2024, closing 8 positions and reducing 3 holdings. Its most notable exit was Canadian Imperial Bank of Commerce, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 50% of assets, up from 48% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Portland Investment Counsel opened a new position in State Street SPDR Bloomberg 1-3 Month T-Bill ETF worth $1.05M.

  • Portland Investment Counsel's largest Q3 2024 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 11,467 shares worth $1.05M.
  • Portland Investment Counsel added most to Oklo in Q3 2024, an estimated $5.9M increase.
  • Portland Investment Counsel's biggest Q3 2024 reduction was AT&T, cutting an estimated $589K.
  • Portland Investment Counsel fully exited Canadian Imperial Bank of Commerce in Q3 2024, selling an estimated $10.5M.
  • Portland Investment Counsel's ten largest holdings make up 79% of its $278M portfolio in Q3 2024.
  • Portland Investment Counsel opened 7 new positions and closed 8 in Q3 2024.
  • Portland Investment Counsel's portfolio value rose 0.31% quarter-over-quarter to $278M.

Based on Portland Investment Counsel's 13F filing for Q3 2024, filed 14 Nov 2024.